In focus · trending topic

Johnson & Johnson

11 stories · following the connections

Agile Therapeutics Announces Positive Top-line Phase 3 Results

By Nasdaq OMXJan 3, 2017, 9:11 PM UTC

Boyden's Leadership Series Features Dean Foods’ Ralph Scozzafava

By Nasdaq OMXAug 31, 2016, 9:45 AM UTC

Agile Therapeutics Appoints Ajit S. Shetty, Ph.D., to Its Board of Directors

By Nasdaq OMXFeb 24, 2016, 9:15 PM UTC